Dompé Holdings
Also known as Dompé Holdings S.r.l., Dompe Holdings, Dompé Holdings S.r.l. a socio unico
Milan holding wholly owned by Sergio Dompé: parent of Dompé Farmaceutici, holder of 44.4% of BF under a pact with Arum, and investor in startups, VC funds and listed companies.
USEFUL FOR Fund managers raising capital · Founders · Business owners seeking a long-term partner · Co-investors
Milan holding company of Sergio Dompé, parent of Dompé Farmaceutici S.p.A.; not the pharmaceutical operating company itself.
Family & background
- FAMILY
- Dompé
- WEALTH ORIGIN
- Pharmaceuticals (Dompé Farmaceutici)
- HEADQUARTERS
- Milan, Italy
- OUTSIDE CAPITAL
- No — own capital only
Investment approach
- GEOGRAPHY
- ItalyGlobal
- STAGES
- SeedSeries AGrowth
- ROUTES
- Companies (own capital) · Funds (as LP)
- STRATEGIES
- Direct investmentsVenture capitalPublic equities
Overview
Dompé Holdings S.r.l. is the parent company of the Dompé group and is wholly owned by Sergio Dompé. Its 2025 directors’ report describes two main activities, venture capital (“investment club”) and holding, plus a secondary securities-portfolio activity. Besides control of Dompé Farmaceutici S.p.A., it holds stakes in companies such as B.F. S.p.A., Technoprobe, Directa Plus, Philogen and Talent Garden, and commitments to Social+Capital, Embarcadero, Equinox III and NB Aurora funds. In 2026 it bought BF shares in a joint tender offer with Arum S.p.A. and, per the updated shareholders’-agreement disclosure, holds 44.432% of BF.
Investment thesis
Per its 2025 directors’ report: professional risk-capital investments from its own resources, mainly in small or very small companies in early phases with strong growth potential, supported with strategic advice and financing; plus holding and securities-portfolio activities.
Holdings & investments (19)
- Dompé Farmaceutici S.p.A.NOTABLEBiotech & Life Sciences
- B.F. S.p.A. (BF)NOTABLEFood & Agriculture
- BF International Best Fields Best Food LimitedFood & Agriculture
- Philogen S.p.A.Biotech & Life Sciences
- Movendo Technology S.r.l.HealthTech
- Technoprobe S.p.A.Deep Tech
- Directa Plus plcDeep Tech
- Asset Italia S.p.A.
- Talent GardenEducation
- Palmetto Clean Technology Inc.Climate & Energy
- Beast (Mr. Beast) preferred sharesMedia & Entertainment
- The Equity Club S.r.l.
- Tec Cyber S.p.A.
- TEC Movie S.p.A.Media & Entertainment
- Engitix LtdBiotech & Life Sciences
- The Social+Capital Partnership funds (fund commitments)
- Embarcadero Venture Partners (fund)
- Equinox III (fund)
- NB Aurora S.A. (fund)
People
- Sergio DompéChairman and sole shareholder · source
Frequently asked questions
Dompé Holdings is a family holding based in Milan, Italy.
Dompé Holdings invests on behalf of the Dompé family (Pharmaceuticals (Dompé Farmaceutici)).
Dompé Holdings invests its own capital into companies and in third-party funds as an LP. Its stated asset mix includes direct investments, venture capital and public equities.
Dompé Holdings invests at Seed, Series A and Growth stages in Biotech & Life Sciences, Food & Agriculture, Deep Tech, Climate & Energy and Media & Entertainment.
Key people at Dompé Holdings include Sergio Dompé (Chairman and sole shareholder).
Dompé Holdings's holdings and investments include Dompé Farmaceutici S.p.A., B.F. S.p.A. (BF), BF International Best Fields Best Food Limited, Philogen S.p.A., Movendo Technology S.r.l., Technoprobe S.p.A., Directa Plus plc and Asset Italia S.p.A., among others.
The most recent publicly reported investment by Dompé Holdings is B.F. S.p.A. (BF) (Joint voluntary tender offer with Arum S.p.A. at €5.00 per share; 38.933% of BF tendered, half bought by Dompé Holdings (about €255M); offerors and concert parties reached 88.057% of BF; payment 10 July 2026), announced in Jul 2026.
No. Dompé Holdings invests its own capital and does not raise money from outside investors.